The global market for Bio Pharma Buffer was valued at US$ 966 million in the year 2024 and is projected to reach a revised size of US$ 1561 million by 2031, growing at a CAGR of 7.2% during the forecast period.
A buffer solution is comprised of a weak conjugate acid-base pair, for example, a weak acid and its conjugate base, or a weak base and its conjugate acid. Small quantities of other acids or bases are neutralized when added to the solution, and as a result, the solution resists changes in pH. Solutions with stable pH are required for the processing of protein-based biologic APIs because of their sensitivity to changes in pH. The stable pH range and capacity (the amount of acid/base that can be added without a change in pH) of a buffer are determined by the conjugate acid-base pair.
Most purification steps for downstream processing of biologics require buffers to equilibrate, condition, wash, elute, or concentrate the product. They are used in product isolation and purification steps to facilitate protein capture and polishing and also in the filtration process for the removal of viruses or depyrogenation. Aqueous solutions are also required for cleaning and disinfecting downstream processing equipment, such as chromatography matrices and membrane filtration systems. The main equipment involved in downstream processing with buffers includes mixers for buffer preparation, as well as equipment for purification, including packed-bed chromatography systems, fluidized beds, ultrafiltration and diafiltration membranes, microfiltration membranes, depth filtration cartridges, and virus-removal systems.
The key players are Avantor, Alfa Aesar (Thermo Fisher), Merck, Lonza, Bio-Rad, BD, GE, Healthcare, Promega Corporation, Hamilton Company, XZL BIO-TECHNOLOGY, SRL and so on. According to the revenue of these companies, we can know that the Bio Pharma Buffer industry is relative concentrated. Because the top 6 companies have more than 70% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bio Pharma Buffer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bio Pharma Buffer.
The Bio Pharma Buffer market size, estimations, and forecasts are provided in terms of sales volume (K Liter) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bio Pharma Buffer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bio Pharma Buffer manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Avantor
Alfa Aesar (Thermo Fisher)
Merck
Lonza
Bio-Rad
BD
GE Healthcare
Promega Corporation
Hamilton Company
XZL BIO-TECHNOLOGY
SRL
Segment by Type
Phosphates Type
Acetates Type
TRIS Type
Others
Segment by Application
Research Institution
Pharmaceutical Industry
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bio Pharma Buffer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bio Pharma Buffer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Bio Pharma Buffer Market Overview
1.1 Product Definition
1.2 Bio Pharma Buffer by Type
1.2.1 Global Bio Pharma Buffer Market Value Comparison by Type (2024 VS 2031)
1.2.2 Phosphates Type
1.2.3 Acetates Type
1.2.4 TRIS Type
1.2.5 Others
1.3 Bio Pharma Buffer by Application
1.3.1 Global Bio Pharma Buffer Market Value by Application (2024 VS 2031)
1.3.2 Research Institution
1.3.3 Pharmaceutical Industry
1.3.4 Others
1.4 Global Bio Pharma Buffer Market Size Estimates and Forecasts
1.4.1 Global Bio Pharma Buffer Revenue 2020-2031
1.4.2 Global Bio Pharma Buffer Sales 2020-2031
1.4.3 Global Bio Pharma Buffer Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Bio Pharma Buffer Market Competition by Manufacturers
2.1 Global Bio Pharma Buffer Sales Market Share by Manufacturers (2020-2025)
2.2 Global Bio Pharma Buffer Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Bio Pharma Buffer Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Bio Pharma Buffer, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bio Pharma Buffer, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bio Pharma Buffer, Product Type & Application
2.7 Global Key Manufacturers of Bio Pharma Buffer, Date of Enter into This Industry
2.8 Global Bio Pharma Buffer Market Competitive Situation and Trends
2.8.1 Global Bio Pharma Buffer Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Bio Pharma Buffer Players Market Share by Revenue
2.8.3 Global Bio Pharma Buffer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Bio Pharma Buffer Market Scenario by Region
3.1 Global Bio Pharma Buffer Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Bio Pharma Buffer Sales by Region: 2020-2031
3.2.1 Global Bio Pharma Buffer Sales by Region: 2020-2025
3.2.2 Global Bio Pharma Buffer Sales by Region: 2026-2031
3.3 Global Bio Pharma Buffer Revenue by Region: 2020-2031
3.3.1 Global Bio Pharma Buffer Revenue by Region: 2020-2025
3.3.2 Global Bio Pharma Buffer Revenue by Region: 2026-2031
3.4 North America Bio Pharma Buffer Market Facts & Figures by Country
3.4.1 North America Bio Pharma Buffer Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Bio Pharma Buffer Sales by Country (2020-2031)
3.4.3 North America Bio Pharma Buffer Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Bio Pharma Buffer Market Facts & Figures by Country
3.5.1 Europe Bio Pharma Buffer Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Bio Pharma Buffer Sales by Country (2020-2031)
3.5.3 Europe Bio Pharma Buffer Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bio Pharma Buffer Market Facts & Figures by Region
3.6.1 Asia Pacific Bio Pharma Buffer Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Bio Pharma Buffer Sales by Region (2020-2031)
3.6.3 Asia Pacific Bio Pharma Buffer Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Bio Pharma Buffer Market Facts & Figures by Country
3.7.1 Latin America Bio Pharma Buffer Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Bio Pharma Buffer Sales by Country (2020-2031)
3.7.3 Latin America Bio Pharma Buffer Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bio Pharma Buffer Market Facts & Figures by Country
3.8.1 Middle East and Africa Bio Pharma Buffer Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Bio Pharma Buffer Sales by Country (2020-2031)
3.8.3 Middle East and Africa Bio Pharma Buffer Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Bio Pharma Buffer Sales by Type (2020-2031)
4.1.1 Global Bio Pharma Buffer Sales by Type (2020-2025)
4.1.2 Global Bio Pharma Buffer Sales by Type (2026-2031)
4.1.3 Global Bio Pharma Buffer Sales Market Share by Type (2020-2031)
4.2 Global Bio Pharma Buffer Revenue by Type (2020-2031)
4.2.1 Global Bio Pharma Buffer Revenue by Type (2020-2025)
4.2.2 Global Bio Pharma Buffer Revenue by Type (2026-2031)
4.2.3 Global Bio Pharma Buffer Revenue Market Share by Type (2020-2031)
4.3 Global Bio Pharma Buffer Price by Type (2020-2031)
5 Segment by Application
5.1 Global Bio Pharma Buffer Sales by Application (2020-2031)
5.1.1 Global Bio Pharma Buffer Sales by Application (2020-2025)
5.1.2 Global Bio Pharma Buffer Sales by Application (2026-2031)
5.1.3 Global Bio Pharma Buffer Sales Market Share by Application (2020-2031)
5.2 Global Bio Pharma Buffer Revenue by Application (2020-2031)
5.2.1 Global Bio Pharma Buffer Revenue by Application (2020-2025)
5.2.2 Global Bio Pharma Buffer Revenue by Application (2026-2031)
5.2.3 Global Bio Pharma Buffer Revenue Market Share by Application (2020-2031)
5.3 Global Bio Pharma Buffer Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Avantor
6.1.1 Avantor Company Information
6.1.2 Avantor Description and Business Overview
6.1.3 Avantor Bio Pharma Buffer Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Avantor Bio Pharma Buffer Product Portfolio
6.1.5 Avantor Recent Developments/Updates
6.2 Alfa Aesar (Thermo Fisher)
6.2.1 Alfa Aesar (Thermo Fisher) Company Information
6.2.2 Alfa Aesar (Thermo Fisher) Description and Business Overview
6.2.3 Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Product Portfolio
6.2.5 Alfa Aesar (Thermo Fisher) Recent Developments/Updates
6.3 Merck
6.3.1 Merck Company Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Bio Pharma Buffer Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merck Bio Pharma Buffer Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Lonza
6.4.1 Lonza Company Information
6.4.2 Lonza Description and Business Overview
6.4.3 Lonza Bio Pharma Buffer Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Lonza Bio Pharma Buffer Product Portfolio
6.4.5 Lonza Recent Developments/Updates
6.5 Bio-Rad
6.5.1 Bio-Rad Company Information
6.5.2 Bio-Rad Description and Business Overview
6.5.3 Bio-Rad Bio Pharma Buffer Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Bio-Rad Bio Pharma Buffer Product Portfolio
6.5.5 Bio-Rad Recent Developments/Updates
6.6 BD
6.6.1 BD Company Information
6.6.2 BD Description and Business Overview
6.6.3 BD Bio Pharma Buffer Sales, Revenue and Gross Margin (2020-2025)
6.6.4 BD Bio Pharma Buffer Product Portfolio
6.6.5 BD Recent Developments/Updates
6.7 GE Healthcare
6.7.1 GE Healthcare Company Information
6.7.2 GE Healthcare Description and Business Overview
6.7.3 GE Healthcare Bio Pharma Buffer Sales, Revenue and Gross Margin (2020-2025)
6.7.4 GE Healthcare Bio Pharma Buffer Product Portfolio
6.7.5 GE Healthcare Recent Developments/Updates
6.8 Promega Corporation
6.8.1 Promega Corporation Company Information
6.8.2 Promega Corporation Description and Business Overview
6.8.3 Promega Corporation Bio Pharma Buffer Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Promega Corporation Bio Pharma Buffer Product Portfolio
6.8.5 Promega Corporation Recent Developments/Updates
6.9 Hamilton Company
6.9.1 Hamilton Company Company Information
6.9.2 Hamilton Company Description and Business Overview
6.9.3 Hamilton Company Bio Pharma Buffer Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Hamilton Company Bio Pharma Buffer Product Portfolio
6.9.5 Hamilton Company Recent Developments/Updates
6.10 XZL BIO-TECHNOLOGY
6.10.1 XZL BIO-TECHNOLOGY Company Information
6.10.2 XZL BIO-TECHNOLOGY Description and Business Overview
6.10.3 XZL BIO-TECHNOLOGY Bio Pharma Buffer Sales, Revenue and Gross Margin (2020-2025)
6.10.4 XZL BIO-TECHNOLOGY Bio Pharma Buffer Product Portfolio
6.10.5 XZL BIO-TECHNOLOGY Recent Developments/Updates
6.11 SRL
6.11.1 SRL Company Information
6.11.2 SRL Description and Business Overview
6.11.3 SRL Bio Pharma Buffer Sales, Revenue and Gross Margin (2020-2025)
6.11.4 SRL Bio Pharma Buffer Product Portfolio
6.11.5 SRL Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bio Pharma Buffer Industry Chain Analysis
7.2 Bio Pharma Buffer Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bio Pharma Buffer Production Mode & Process Analysis
7.4 Bio Pharma Buffer Sales and Marketing
7.4.1 Bio Pharma Buffer Sales Channels
7.4.2 Bio Pharma Buffer Distributors
7.5 Bio Pharma Buffer Customer Analysis
8 Bio Pharma Buffer Market Dynamics
8.1 Bio Pharma Buffer Industry Trends
8.2 Bio Pharma Buffer Market Drivers
8.3 Bio Pharma Buffer Market Challenges
8.4 Bio Pharma Buffer Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Avantor
Alfa Aesar (Thermo Fisher)
Merck
Lonza
Bio-Rad
BD
GE Healthcare
Promega Corporation
Hamilton Company
XZL BIO-TECHNOLOGY
SRL
听
听
*If Applicable.